Citius Pharmaceuticals, Inc.
NASDAQ:CTXR
Overview | Financials
Company Name | Citius Pharmaceuticals, Inc. |
Symbol | CTXR |
Currency | USD |
Price | 3.56 |
Market Cap | 30,155,834 |
Dividend Yield | 0% |
52-week-range | 2.44 - 26.75 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Leonard L. Mazur |
Website | https://www.citiuspharma.com |
An error occurred while fetching data.
About Citius Pharmaceuticals, Inc.
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic lock solution to treat patients with catheter-related
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD